Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 3/20 | 0.38 |
| ▸ | CREBBP | Q92793 | 3/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22902081 | 1.00 | BRD4 (0.38) | BRD4CREBBPEP300CRBN | |
| SCHEMBL7536500 | 0.72 | — | — | |
| SCHEMBL9306449 | 0.72 | — | — | |
| SCHEMBL20614486 | 0.72 | CREBBP (0.52) | BRD4CREBBPEP300CRBN | |
| SCHEMBL25838829 | 0.69 | — | — | |
| SCHEMBL357257 | 0.69 | — | — | |
| SCHEMBL12160740 | 0.69 | — | — | |
| SCHEMBL16274298 | 0.68 | CES2 (0.34) | CRBN | |
| SCHEMBL16274311 | 0.68 | CES2 (0.34) | CRBN | |
| SCHEMBL11273146 | 0.68 | CES2 (0.34) | CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12152107-B2 | Isomer-enriched 3-caranlactams and polyamides based thereon with high optical purity and adjustable crystallinity for high-performance applications | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-11-26 | — | — | US | disclosed |
| US-20210017332-A1 | ISOMER-ENRICHED 3-CARANLACTAMS AND POLYAMIDES BASED THEREON WITH HIGH OPTICAL PURITY AND ADJUSTABLE CRYSTALLINITY FOR HIGH-PERFORMANCE APPLICATIONS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2021-01-21 | — | — | US | disclosed |
| US-20210017332-A1 | ISOMER-ENRICHED 3-CARANLACTAMS AND POLYAMIDES BASED THEREON WITH HIGH OPTICAL PURITY AND ADJUSTABLE CRYSTALLINITY FOR HIGH-PERFORMANCE APPLICATIONS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2021-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210017332-A1 | ISOMER-ENRICHED 3-CARANLACTAMS AND POLYAMIDES BASED THEREON WITH HIGH OPTICAL PURITY AND ADJUSTABLE CRYSTALLINITY FOR HIGH-PERFORMANCE APPLICATIONS | NOTUM, MGAM, CARM1 | BRD4 3989/4885CREBBP 2307/4885EP300 3182/4885 |
| US-12152107-B2 | Isomer-enriched 3-caranlactams and polyamides based thereon with high optical purity and adjustable crystallinity for high-performance applications | NOTUM, MGAM, CARM1 | BRD4 3989/4885CREBBP 2307/4885EP300 3182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.